title: The Fhit protein: an opportunity to overcome chemoresistance.
authors.affiliation: Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH, USA.|Lymphoma & Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland.|Dipartimento di Medicina Sperimentale e Clinica, University , Catanzaro, Italy.
authors.forename: Eugenio
authors.initials: E
authors.lastname: Gaudio
authors.affiliation: Dipartimento di Medicina Sperimentale e Clinica, University , Catanzaro, Italy.|Tecnologica Research Institute, Biomedical Section, Crotone, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Paduano
authors.affiliation: Department of Molecular Immunology, Virology and Medical Genetics, The Ohio State University, Columbus, OH, USA.
authors.forename: Carlo M
authors.initials: CM
authors.lastname: Croce
authors.affiliation: Dipartimento di Medicina Sperimentale e Clinica, University , Catanzaro, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Trapasso
mesh_terms: D017766:Acid Anhydride Hydrolases / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism; D000099170:Bis(5'-adenosyl)triphosphatase
chemical_list: D017766:Acid Anhydride Hydrolases; D009363:Neoplasm Proteins; D000099170:Bis(5'-adenosyl)triphosphatase
keywords: Fragile Histidine Triad (FHIT); mimetic peptides; reactive oxygen species; targeted therapy; tumor suppressor